These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8463922)

  • 21. Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure.
    Braun A; Ding R; Seidel C; Fies T; Kurtz A; Schärer K
    Pediatr Nephrol; 1993 Feb; 7(1):61-4. PubMed ID: 8439481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.
    Yasmeen BH; Chowdhury MA; Hoque MM; Hossain MM; Jahan R; Akhtar S
    Bangladesh Med Res Counc Bull; 2012 Dec; 38(3):119-23. PubMed ID: 23540189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers.
    McMahon FG; Vargas R; Ryan M; Jain AK; Abels RI; Perry B; Smith IL
    Blood; 1990 Nov; 76(9):1718-22. PubMed ID: 2224121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double blind trial of recombinant human erythropoietin in preterm infants.
    Nicholson RH
    Arch Dis Child; 1993 Nov; 69(5 Spec No):542. PubMed ID: 8285765
    [No Abstract]   [Full Text] [Related]  

  • 25. Double blind trial of recombinant human erythropoietin in preterm infants.
    Emmerson AJ; Coles HJ; Stern CM; Pearson TC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):291-6. PubMed ID: 8466265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects.
    Widness JA; Veng-Pedersen P; Peters C; Pereira LM; Schmidt RL; Lowe LS
    J Appl Physiol (1985); 1996 Jan; 80(1):140-8. PubMed ID: 8847295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.
    Shireman TI; Hilsenrath PE; Strauss RG; Widness JA; Mutnick AH
    Arch Pediatr Adolesc Med; 1994 Jun; 148(6):582-8. PubMed ID: 8193681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of epoetin (erythropoietin) in the anemia of prematurity.
    Novick D; Moore TB; Feig SA
    West J Med; 1995 Apr; 162(4):355-6. PubMed ID: 7747503
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recombinant erythropoietin and early preterm neonatal anemia].
    Piasetskaia NM
    Lik Sprava; 1999 Jun; (4):47-51. PubMed ID: 10476641
    [No Abstract]   [Full Text] [Related]  

  • 30. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
    Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of recombinant human erythropoietin in the treatment of anemia of prematurity].
    Rosati E; Latini G; De Mitri B; Quartulli L; Caliandro P
    Pediatr Med Chir; 1995; 17(1):45-8. PubMed ID: 7739926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin in anemia of prematurity.
    Gupte S
    Indian J Pediatr; 2003 Mar; 70(3):271. PubMed ID: 12785302
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.
    Carnielli V; Montini G; Da Riol R; Dall'Amico R; Cantarutti F
    J Pediatr; 1992 Jul; 121(1):98-102. PubMed ID: 1625101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity.
    Halpérin DS; Félix M; Wacker P; Lacourt G; Babel JF; Wyss M
    Eur J Pediatr; 1992 Sep; 151(9):661-7. PubMed ID: 1396927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
    Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biology of erythropoietin and its role in the anaemia of prematurity.
    Kannourakis G
    J Paediatr Child Health; 1994 Aug; 30(4):293-5. PubMed ID: 7946536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.